The treatment, now available in England, targets myeloma, a blood cancer affecting plasma cells in the bone marrow. It ...

When it comes to vaccines, where they go into your body can make a surprising difference in how well they work. Scientists in ...

This valuable manuscript investigates the localisation of nutrient receptors in bloodstream stage trypanosomes, with implications for both nutrient uptake and immune evasion. Results after direct ...

A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world ...

EXCLUSIVE: A top doctor has shared five common symptoms which could be a sign that something is seriously wrong.

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

Recent innovations across the multiple ADC components, such as enhanced antibody-targeting to the tumors, better linker ...

Government data projects nearly 620,000 cancer deaths in the U.S. this year. However, a new "Trojan horse" therapy could ...

Jacob E. Berchuck, MD, discusses research on plasma epigenomic profiling in metastatic castration-resistant prostate cancer.

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...